Free Cash Flow

Chembio Diagnostics, Inc. (CEMI)

$ 3.91
0.58 (+19.73%)

Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 29.5527.6524.2617.8724.0233.4134.4630.4531.3232.2233.1434.0835.06
Revenue (%)
Operating Cash Flow 2.28-3.821.79-6.70-5.03-11.78-9.06-18.89-7.08-7.28-7.49-7.70-7.92
Operating Cash Flow (%)
Capital Expenditure -0.89-1.45-1.03-0.12-1.03-1.47-3.80-4.17-1.82-1.87-1.93-1.98-2.04
Capital Expenditure (%)
Free Cash Flow 1.39-5.270.76-6.82-6.06-13.25-12.86-23.05-8.90-9.15-9.41-9.68-9.96

FCF Unlevered from cash flow statement